The role of estrogen-receptor alpha (ERa) in the pathogenesis of diabetes and cardiovascular disease.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/526693

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cardiovascular disease (CVD), including heart attack and stroke, causes more deaths in Australia than any other disease. A major risk factor for CVD is diabetes, which affects more than 1 million Australians. Therefore, treating diabetes will reduce the number of people likely to die from CVD. This project aims to investigate a recently identified role for estrogen in the protection against diabetes. If successful, findings from this project may lead to new treatments against diabetes and CVD.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2015

Funding Scheme: Early Career Fellowships

Funding Amount: $374,757.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cell Metabolism

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiovascular disease | diabetes | insulin resistance | nuclear receptors

Related Links